About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

TERMINATED

Cardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive Testing

NCT05699265•Children's Hospital Medical Center, Cincinnati

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Fabry Disease

Interventions

Measures of arterial stiffness and endothelial function

Ambulatory blood pressure monitoring

+2 more

Locations

1

United States

Locations (1)

Cincinnati Children's Hospital

Cincinnati, Ohio, United States

Key Dates

Start Date

February 1, 2023

Primary Completion Date

April 1, 2025

Completion Date

April 1, 2025

Last Updated

June 19, 2025

Related Studies

Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding

NCT06941025

Fabry DiseasePregnancy+1 more

Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes

NCT07382128

HCM - Hypertrophic CardiomyopathyAnderson Fabry Disease+2 more

T1 Mapping in Fabry Disease

NCT05923788

Taiwan Associated Genetic and Nongenetic Small Vessel Disease

NCT05473637

Cerebral Small Vessel DiseasesCadasil+6 more

Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment

NCT07277361

Fabry DiseaseAged 65 Years or Older+2 more

A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding

NCT04252066

View all related studies

Sponsors

Lead Sponsor

Children's Hospital Medical Center, Cincinnati

Collaborators

Sanofi

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 19, 2025Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions